Rusnano, Domain to invest $760m in drug production facility
The joint venture will manage advanced-stage clinical trials in Russia of new pharmaceuticals and other products that will support regulatory approval of these products in Russia, the US
Isomorphic Labs has raised $5bn in a Series C financing round to support the development of its AI platform and advance its therapeutic candidates towards clinical evaluation.
According to the study, patients with more severe symptoms achieved a greater improvement following treatment with the ToleroMune T-cell vaccine than those on placebo (p=0.05). Therandomized, double-blind studywas
The Revitas revenue management solution allows pharmaceutical manufacturers to minimise the payment of erroneous claims for rebate and administrative fee payments by validating rebate claims for individual prescriptions.